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Abstract
Background—The mechanisms of sudden death in chronic kidney disease (CKD) remain 
unclear.
Objective—To test the hypotheses that subcutaneous nerve activity (SCNA) can be used to 
estimate sympathetic tone in ambulatory rats and that abrupt reduction of SCNA precedes the 
spontaneous arrhythmic death of Cy/+ rats.
Methods—Radiotransmitters were implanted in ambulatory normal (N=6) and Cy/+ (CKD; N=6) 
rats to record electrocardiogram and SCNA. Two additional rats were studied before and after 
chemical sympathectomy with 6-hydroxydopamine (6-OHDA).
Results—In normal rats, the baseline HR and SCNA were 351±29 bpm 5.12±2.97 mV-s, 
respectively; SCNA abruptly increased heart rate (HR) by 4.31% (95% confidence interval, CI, 
4.15% to 4.47%). In comparison, the CKD rats had reduced baseline HR (336±21 bpm, p<0.01) 
and SCNA (4.27±3.19 mV-s, p<0.01). When SCNA was observed, the HR increased by only 
2.48% (CI, 2.29% to 2.67%, p<0.01). All Cy/+ rats died suddenly, preceded by sinus bradycardia, 
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advanced (2nd and 3rd degree) atrioventricular (AV) block (N=6) and/or ventricular tachycardia or 
fibrillation (N=3). Sudden death was preceded by a further reduction of SCNA (3.22±2.86 mV-s, 
p<0.01) and sinus bradycardia (243±55 bpm, p<0.01). Histological studies showed myocardial 
calcification in CKD rats that involved the conduction system. Chemical sympathectomy resulted 
in progressive reduction of SCNA over 7 days.
Conclusions—SCNA can be used to estimate sympathetic tone in ambulatory rats. CKD is 
associated with reduced HR response to SCNA and conduction system diseases. Abrupt reduction 
of sympathetic tone precedes AV block, ventricular arrhythmia and sudden death of the CKD rats.
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subcutaneous nerve activity; sudden death; AV block; Chronic Kidney Disease
In patients with chronic kidney disease (CKD) on dialysis, 25% of cardiovascular mortality 
were caused by sudden cardiac death (SCD), a 100-fold increase compared with the general 
population.1 The mechanisms of SCD in patients with CKD were diverse, but sinus 
bradycardia, atrioventricular (AV) block and ventricular tachyarrhythmia have been 
frequently observed.2, 3 One of the possible pathophysiological changes associated with the 
CKD is abnormal activity of the sympathetic nervous system.4, 5 Sympathetic hyperactivity 
is a cause of hypertension, which may contribute to the development of CKD. However, a 
direct relationship between sympathetic nerve activity and SCD in CKD has not been 
demonstrated. Cy/+ rat is a Han:SPRD rat with autosomal dominant polycystic kidney 
disease that is slowly progressive. These rats accurately reproduce many of the changes 
associated with human CKD including hypertension, left ventricular hypertrophy and 
mineral bone disorder.6, 7 Importantly, we observed a high incidence of sudden death of the 
CKD rats after 35 weeks of age prompting evaluation of possible cardiac etiologies. Cardiac 
ion channel and calcium handling are abnormal in these CKD rats.8 These abnormalities 
may increase ventricular arrhythmogenesis and result in SCD. However, the terminal 
arrhythmia causing SCD remains unclear. We recently reported that subcutaneous nerve 
activity (SCNA) can be used to estimate sympathetic tone in ambulatory dogs.9–11 We 
hypothesized that if this technique can be applied to rats that it would allow determination of 
the sympathetic nerve activity at the time of SCD. The purpose of the present study was to 
continuously record electrocardiogram (ECG) and subcutaneous nerve activity (SCNA) in 
CKD rats to test the hypothesis that abnormal sympathetic nerve activities are immediate 
triggers of SCD.
Materials and Methods
Animal Model
Eight normal and six CKD male rats were used in this study. The CKD rat is a spontaneous 
cystic kidney disease model with a defect in the samcystin (Cy) gene. However, unlike other 
models of cystic kidney disease,12 the samcystin protein does not affect the cilia but instead, 
binds to a cytoplasmic RNA binding protein bicc-1.13, 14 Male heterozygous rats develop 
characteristics of CKD (azotemia or elevated blood urea nitrogen [BUN]) around 10 weeks 
of ages, which thereafter slowly progresses to terminal uremia (symptomatic kidney disease) 
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by about 40 weeks. This animal model spontaneously develops manifestations of CKD, 
including biochemical abnormalities, hypertension, left ventricular hypertrophy, renal 
osteodystrophy and arterial calcification.6, 7, 15, 16 Animals had periodic blood tests for 
analyses of calcium, phosphorus, parathyroid hormone and BUN using previously published 
methods.6 Five animals also had potassium and magnesium measured using hospital 
laboratory colorimetric techniques. Six normal Han:SPRD rats of similar (35-weeks) age 
underwent DSI monitoring to serve as control. All procedures were approved by the Indiana 
University School of Medicine Institutional Animal Care and Use Committee.
Continuous ECG and SCNA Recordings
All rats underwent surgery at 35-weeks of age under isoflurane inhalation anesthesia. A 3.0 
cm midline incision was made through the dorsal skin for the implantation of a Data Science 
International (DSI; St Paul, Minnesota) model PhysioTel® ETA-F10 (5 CKD and 5 normal 
rats) or F50-W-F2 (1 CKD and 1 normal rat) radiotransmitters. The two bipolar recording 
wires were tunneled subcutaneously from the top of the dorsal incision subcutaneously to 
the forelimbs, with one wire for each limb. The transmitter was then secured in a 
subcutaneous pocket and the rats were allowed to recover. ECG and SCNA signals were 
sampled continuously at 1,000 times/s and transmitted to a receiver placed at the bottom of 
the rat cage. The data were then digitized for offline analyses. The recordings continued in 
CKD rats until the time of SCD. For comparison, 6 normal rats underwent the same surgical 
procedures performed by the same surgeon. After 2 weeks of recovery, continuous 
recordings were made for 3 weeks before euthanasia.
An additional 2 normal rats were studied to determine the effects of chemical 
sympathectomy on SCNA. These rats underwent 5 days of baseline recording, followed by 
intraperitoneal injection of 6-hydroxydopa (6-OHDA) (100 mg/kg) 1 and 4 days after 
baseline recording. The SCNA and ECG continued until 7 days after baseline recording.
Histological Examinations
The entire rat heart was fixed in 4% formalin for 45 min, followed by storage in 70% 
alcohol. The tissues were processed routinely, paraffin embedded and cut into 5-μm thick 
sections. Trichrome stains and the hematoxylin and eosin stains were performed on all 
specimens. The slides were then examined using a light microscope.
Data Analyses
Using a custom-written software, we manually analyzed the recording from CKD rats at 5 
days prior to death for baseline activity and also at 24 hours prior to death. Data from normal 
rats were also analyzed manually for comparison. Noise and artifacts were eliminated during 
manual analyses. Low frequency noise was eliminated with high pass filters. The filtered 
signals were then rectified, integrated within 100-ms time windows and summed to represent 
integrated subcutaneous nerve activity (iSCNA) of 10-s segments. Because integration was 
performed, the quantitative data considered both amplitude (voltage) and frequency of nerve 
activity. We also manually identified SCNA episodes by a 3-fold increase of SCNA 
amplitude over baseline noise. The onset of each SCNA episode was used as time zero. We 
then determined the iSCNA and average heart rate (HR) 3-s prior to and 3-s after the time 
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zero to test the hypothesis that SCNA is associated with HR elevation. Figure 1 shows the 
methods used to determine whether or not SCNA increased HR.
Statistical Analysis
The descriptive data were expressed as mean ± SD while the data used for quantitative 
comparison were expressed as confidence interval.17 Paired t tests were used to compare the 
means of two groups. Bonferroni correction was made for multiple comparisons. A two 
tailed P value of ≤0.05 was considered statistically significant. Generalized additive mixed-
effects models were used to analyze circadian patterns of SCNA and HR. All analyses were 
performed using IBM SPSS software 22.0 (IBM SPSS, Chicago, IL) and R 3.0.1.
Results
Relationship between SCNA and heart rate
SCNA increased an average HR of 360±21 bpm to 376±21 bpm in normal rats during the 5 
day monitoring period. The average increase was 4.31% (CI, 4.15% to 4.47%, P=0.027, 
Figures 1A and 1B). In comparison, SCNA increased from a HR of 356±16 bpm to 364±19 
bpm in CKD rats over the 5 days prior to death. The average increase in the CKD rats was 
only 2.48% (CI, 2.29% to 2.67%, p<0.01 compared to normal rats). The effects of SCNA on 
HR were further reduced within 24 hours of death, when the SCNA showed an increased HR 
from 243±60 bpm to 245±64 bpm (increase by 0.54%, CI, 0.43% to 0.66%, p<0.01). These 
data show that SCNA can be used to measure sympathetic tone in both normal and CKD 
rats. The sinus node response to SCNA is reduced by CKD, especially prior to death. In two 
rats, the data were obtained using an F50-W-F2 transmitter that has a high sampling rate of 
5000 Hz and band width of 50–1000 Hz, allowing us to high pass filter the signals at 150 
Hz, 500 Hz and 700 Hz to further reduce the lower frequency signals such as ECG and 
muscle contractions. The results (Figure 2) show that significant high frequency signals were 
present even after 700 Hz high pass filtering. Figure 3 shows the number of SCNA episodes 
with various degrees of HR changes, using the baseline HR as 1. In normal rats (blue line), 
the SCNA shows invariable increases in HR. In CKD rats at baseline (5-d prior to death), the 
SCNA also showed nearly uniform increases in HR (red line). However, the magnitude of 
increase was smaller than normal. Within 24-hr before death (green line), the SCNA may be 
associated with either HR acceleration or reduction.
Bradycardia and sudden death in CKD rats
The average 24-hr HR and iSCNA for normal rats were 351±29 bpm and 5.12±2.97 mV-s, 
respectively. The HR and SCNA were, respectively, 336±21 bpm and 4.27±3.19 mV-s for 
CKD rats at baseline (5 days prior to SCD). During the 24-hr period before death in CKD 
rats, the HR was reduced to 243±55 bpm (p<0.001) while SCNA was reduced to 3.22±2.86 
mV-s (p<0.001). Figure 4A and 4B, respectively, show averaged hourly HR and SCNA in 
normal rats and in CKD rats 5 days prior to death. There was significant (p<0.001) circadian 
variation of HR and SCNA in normal rats but not in the CKD rats. Figure 5 shows that 
average hourly HR (Figure 5A) and SCNA (Figure 5B) during the 24 hr period prior to 
death in 5 CKD rats. There was progressive bradycardia in these 5 rats. The 6th rat, which 
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died of spontaneous ventricular fibrillation (VF), did not show progressive HR or SCNA 
reduction within 24-hr of death.
Terminal rhythm in CKD rats
All 6 CKD rats died suddenly 23±14 days after surgery. The underlying rhythm of all rats 
was sinus. Second and third degree AV block occurred in all 6 rats, preceded by a period of 
progressive bradycardia that began within the previous 24 hours. Death, defined by a total 
absence of any synchronized cardiac electrical activity, occurred < 1 hour (range 9 min to 59 
min) after the initial development of AV block. One rat developed 18 episodes of slow 
ventricular tachycardia (VT, Figure 6A) with a heart rate of 77±21 bpm and duration ranging 
from 1.1 s to 17.3 s before converting back to third degree AV block, bradycardia and death. 
Two rats died of ventricular fibrillation (VF, Figure 6B and F) 59 min and 9 min, 
respectively, after the onset of AV block. In the remaining 3 rats, the terminal rhythm was 
complete heart block, progressive bradycardia and asystole (Figures 6C, D and E).
SCNA during ventricular fibrillation
In CKD rat #6, accelerated HR occurred soon after onset of continuous SCNA (Figure 7A, 
arrow 1) and lasted for approximately 15 minutes. When SCNA spontaneously terminated 
(Figure 7B, arrow 3), the rat developed AV block and VF in approximately 3 s (Figure 7B, 
arrow 4). A large burst SCNA occurred roughly 7 s after the onset of VF (Figure 7B, arrow 
5). That large bust persisted for approximately 12 s during continuous VF, most likely 
represents sympathetic responses to circulatory arrest.
Biochemistries
We performed tail vein collection at 35 weeks of age, near the time of DSI placement. The 
mean ± SD for the CKD animals was BUN 47 ± 8 mg/dl, calcium 9.1 ± 3.6 mg/dl (one 
animal was hypercalcemic), phosphorus 8.3 ± 1.7 mg/dl, parathyroid hormone 1,310 ± 1044 
pg/ml, potassium 4.5 ± 1.2 mg/dl, and magnesium 2.9 ± 1.1 mg/dl. Thus, the CKD rats had 
hyperphosphatemia and secondary hyperparathyroidism as we have previously reported and 
is common with progressive CKD.18, 19 Hyperkalemia and hypermagnesemia were not 
observed.
Histological changes
Trichrome staining showed obvious fibrosis in all CKD rats, especially surrounding AV node 
(Figure 8A) and in the subendocardium (Figure 8B). H&E staining showed calcification of 
all 6 CKD rats. The magnitudes of calcification were variable, including small isolated 
calcific deposits in 3 rats, and massive amount of calcific deposits in the remaining 3 rats. In 
the latter rats, the large areas of calcification were observed in the myocardium (Figure 8C) 
and endocardium, and disrupting the conduction system (Figure 8D). In comparison, no 
calcification was found in the conduction system or the myocardium of the normal rats 
(Figure 8E–F).
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Effects of chemical sympathectomy on SCNA
The results of these studies were summarized in an online supplement. Supplemental Figure 
1 shows examples of SCNA before (Panel A) and after (Panel B) 6-OHDA injection. To 
better estimate the effects of 6-OHDA on SCNA, we subtracted the baseline noise, including 
the unfiltered ECGs (red boxes) from the integrated SCNA. The SCNA was stable during the 
baseline recording, but progressively decreased after 6-OHDA (Supplement Figure 2A). The 
mean SCNA reduced from 2.08 mV-s [95% CI, 1.64 to 2.54] on baseline day 5 to 0.48 mV-s 
[95% CI, 0.02 to 0.96] (p<0.001) on day 7 after 6-OHDA injection in rat 1, and from 2.07 
mV-s [95% CI, 1.58 to 2.56] on baseline day 5 to 0.44 mV-s [95% CI, 0.04 to 0.86] 
(p<0.001) after 7 days of injection in rat 2. The mean HR increased from 373 bpm [95% CI, 
358 to 384] to 425 bpm [95% CI, 416 to 435] (p=0.016) in the first rat and from 368 bpm 
[95% CI, 352 to 382] to 392 bpm [95% CI, 374 to 411] (p=0.028) in the second rat 
(Supplemental Figure 2B). The increased HR is a typical response to 6-OHDA.20 There 
were no circadian variations of SCNA (Supplemental Figure 2C) or HR (Supplemental 
Figure 2D) in Day7 after 6-OHDA injection.
Discussion
The major findings of the present study include the following: (1) SCNA can be used to 
estimate the sympathetic tone in rats. (2) Cardiac arrhythmias, including AV block, VT and 
VF underlie the mechanisms of SCD in CKD rats; (3) CKD rats had poor HR response to 
sympathetic activation, especially within 24-hr of SCD.
SCNA and sympathetic tone
Skin and muscle sympathetic nerve activity (SSNA and MSNA, respectively) can be 
recorded by microneurography techniques. Unlike MSNA, the SSNA is identified by broad-
based bursts that are not pulse synchronous.21 The SCNA recorded with widely spaced 
implanted electrodes9–11 is also broad-based and does not track the respiratory modulation 
or beat to beat changes of blood pressure. Both techniques may be helpful in studying the 
sympathetic tone, but only SCNA can be used for long term recording in ambulatory 
animals. In the present study we demonstrated for the first time that SCNA can be recorded 
from a rat model of cardiac arrhythmia. Chemical sympathectomy resulted in a progressive 
reduction of the SCNA, strongly indicating that the SCNA contains a significant sympathetic 
component.
Mechanisms of Sudden Death in CKD rats
We defined SCD by the unexpected death from a cardiac cause within one hour of the onset 
of symptoms.22 According to that definition, all CKD rats used in the present study died of 
SCD. Epidemiological studies have demonstrated the overall incidence of SCD in CKD 
population is significantly greater than the incidence of general population and that the 
incidence increases as CKD progresses.1, 23 Once on dialysis, one in four patients dies 
suddenly and most do not fall into the high-risk categories that are associated with sudden 
death in the general population.24 A recent study showed SCD in CKD was attributable to 
severe bradycardia and asystole during the long interdialytic period.3 Another study 
demonstrated that 74.9% of the clinically significant arrhythmias in previously 
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asymptomatic hemodialysis patients were bradycardia or asystole events while only 1 
sustained VT episodes were detected during the same monitoring period.25 Continuous ECG 
recording in the present study showed that all SCD occurred < 1 hour after the development 
of AV block. While 1 rat developed slow VT and 2 rats died of VF, these tachyarrhythmia 
episodes occurred after the development of AV block. All but one rat developed progressive 
bradycardia prior to the onset of VT or VF, indicating that tachyarrhythmias may be part of 
the terminal events. These data suggest that defibrillation shocks that terminate VT and VF 
may not improve overall survival in patients with advanced CKD.
The causes of AV block remain unclear. Our previous study8 found abnormal ion channel 
function and calcium handling in the CKD rats. These changes may play a role in producing 
sinus bradycardia and AV block. In addition, we found that there was increased fibrosis 
around the AV node and metastatic calcification in all 6 CKD rats, despite overt 
hypercalcemia in only one rat. Masanao et al26 reported an autopsy case of renal transplant 
recipient who died suddenly after a good post-transplant course of 14 years. The 
pathophysiological findings of that case were very similar to our CKD rats, showing 
calcification in the central fibrous body surrounding the AV node and bundle of His, as well 
as in the origin of bifurcating bundle. Others have reported similar findings of calcification 
around AV node or myocardium in dialysis patients who died of AV block.2728 The etiology 
of this extra-skeletal calcification appears to be a result of disordered mineral metabolism 
(hyperphosphatemia and hyperparathyroidism) as was observed in our rats.29 These case 
reports as well as our study suggest that calcification involving the cardiac conduction 
system in CKD may play an important role in the development of AV block and SCD. In 
addition to calcification, cardiac fibrosis is a common finding in pre dialysis and dialysis 
patients that die of cardiac death and undergo autopsy, although calcification was more 
prominent than fibrosis in the current rat study.30, 31 However, because these structural 
changes are likely to have developed over a long time, additional factors are needed to 
explain the trigger of SCD.
SCD and sympathetic withdrawal
There is growing evidence that activation of the sympathetic nervous system contributes to 
the pathogenesis of CKD. Ishii et al32 documented elevated concentrations of plasma 
catecholamines and enhanced sensitivity to norepinephrine in patient with CKD. Increased 
MSNA has also been reported in patients with end-stage renal disease (ESRD) undergoing 
dialysis.33 Consequently, sympathetic activation was recognized as an early 
pathophysiological element of CKD which may have initiated various forms of renal 
damage. In our study, bipolar recording wires were inserted to upper thorax which is 
innervated by sympathetic nerves from the stellate ganglion.34 In the normal rats, the SCNA 
was reliably followed by HR acceleration. However, there was significantly reduced SCNA 
and HR in CKD rats 5-d before death. In a majority of rats, SCD was preceded by further 
reduction of SCNA and HR 24-hr before death. These findings suggest that sympathetic 
withdrawal might have occurred in advanced CKD, and that sudden reduction of 
sympathetic nerve discharges and reduced sinus node response to norepinephrine may have 
facilitated the development of AV block and bradycardia as the terminal events.
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Limitation of the study
We only measured the terminal stages of CKD. Therefore, our data do not imply an absence 
of increased sympathetic tone during early stages of CKD. The SCNA was followed by a 
HR rise of 4.13% in normal rats and 2.48% in CKD rats. The small difference may not have 
significant physiological consequence. However, poor HR response to sympathetic nerve 
activity may contribute to the reduced HR variability in patients with CKD.35
Supplementary Material
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AV atrioventricular
BUN blood urea nitrogen
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DSI data science international
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Clinical Perspectives
We reported the following new findings: (1) It was possible to record SCNA from rats, 
and that the SCNA might be used to estimate cardiac sympathetic tone. These findings 
are consistent with previous reports that documented the efficacy of SCNA in measuring 
sympathetic tone in dogs. Because sympathetic tone is important in the pathogenesis of 
cardiac arrhythmia, the SCNA might become a useful tool in basic science and clinical 
investigations of arrhythmia mechanisms. (2) SCD in Cy/+ rats is triggered invariably by 
AV block and bradycardia. Abrupted withdrawal of sympathetic tone preceded the onset 
of bradycardia and SCD. While VT and VF were also documented in half of the animals 
monitored, they were not triggered directly by sympathetic hyperactivity. Rather, those 
episodes occurred after the onset of AV block. Our findings are consistent with a recent 
report that showed bradycardia as the mechanism of SCD in CKD patients during the 
long interdialytic period. Clinical trials are needed to determine if prevention of 
bradycardia and/or avoiding excessive sympathetic blockade can reduce SCD in patients 
on dialyses.
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Figure 1. 
Heart Rate (HR) and subcutaneous nerve activity (SCNA). A was recorded in a normal rat at 
baseline. We first identified the onset of SCNA (red bar), then determined the average HR 3-
s prior to and 3-s after the onset of SCNA. B shows that in each rat, the HR 3-s after SCNA 
onset was faster than the HR before SCNA onset. C, The same analyses were done for HR 
and SCNA in CKD rats at baseline, showing SCNA induced very little HR change. D shows 
the results of all CKD rats at baseline. The HR changes were less apparent than that 
observed in normal rats.
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Figure 2. 
Subcutaneous nerve activity (SCNA) high pass filtered at 150 Hz, 500 Hz and 700 Hz. 
Because the frequency of electromyogram does not exceed 400 Hz, most of the high 
frequency signals seen after 150 Hz filtering are likely nerve activities.
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Figure 3. 
Number of SCNA episodes associated with different degrees of heart rate change. Normal 
rats are shown in blue. CKD rats 5-d before death is shown in red and 24-hr before death is 
shown in green. The HR of “1” indicates that SCNA did not change the HR. In normal rats, 
practically all SCNA episodes were associated with significant HR increases. The 
magnitudes of change were smaller for CKD rats at baseline, and was even less for CKD rats 
24-hr before death.
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Figure 4. 
HR and SCNA over a 24-hr period in all rats studied. A, There is significant circadian 
variation of HR and SCNA at baseline in normal rats. B, no circadian variations of HR or 
SCNA were observed in CKD rats 5-d before death.
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Figure 5. 
HR and SCNA 24 hours before death. In 5 of 6 CKD rats, there were progressive HR (A) 
and SCNA (B) reduction over a 24-hr period before death. The bradycardias in these 5 rats 
were the results of complete AV block. In one CKD rat, no HR (C) or SCNA (D) changes 
were observed. The latter rat died of VF after a brief period of heart block (see Figure 6F).
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Figure 6. 
Terminal Arrhythmias in CKD rats. A, AV block and slow ventricular tachycardia (VT). B, 
AV block and VF. C, Completed AV block. D, AV block. E, AV block. F, AV block and VF.
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Figure 7. 
SCNA and VF. A, Continuous SCNA started approximately 15-min prior to VF. Arrow 1 
points to SCNA that accelerated the HR. The arrow 2 shows continuous SCNA. B shows the 
onset of VF, which was preceded immediately by SCNA withdrawal (arrow 3), AV block 
and onset of VF occurred (arrow 4). The total duration of AV block in this CKD rat was 
approximately 3-s. Arrow 5 shows a burst of massive SCNA which occurred 7 s after the 
onset of VF and persisted for 12 s (until arrow 6).
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Figure 8. 
Histological findings in CKD (A–D) and in normal (E–F) rats. A, Trichrome staining 
showed fibrosis surrounding AV node (arrows, X200). B, Trichrome staining showed 
fibrosis in endocardium (arrows, X100). C and D, H&E staining showed calcification 
(purple) within the myocardium (X100) and near the endocardium (X100), respectively. E–
F, The AV node (arrows, X200) of normal rats stained with trichrome and H&E, 
respectively. There was no calcification or fibrosis.
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